Arjun Muralidharan

602 total citations
19 papers, 423 citations indexed

About

Arjun Muralidharan is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Arjun Muralidharan has authored 19 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Arjun Muralidharan's work include Pain Mechanisms and Treatments (13 papers), Neuropeptides and Animal Physiology (5 papers) and Bone health and treatments (3 papers). Arjun Muralidharan is often cited by papers focused on Pain Mechanisms and Treatments (13 papers), Neuropeptides and Animal Physiology (5 papers) and Bone health and treatments (3 papers). Arjun Muralidharan collaborates with scholars based in Australia, United States and India. Arjun Muralidharan's co-authors include Maree T. Smith, Bruce Wyse, Trent M. Woodruff, Thomas Walther, Ramamoorthy Rajkumar, Dilip K. Pandey, Radhakrishnan Mahesh, V. S. Rao, Nemat Khan and Andy Kuo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Philosophical Transactions of the Royal Society B Biological Sciences and British Journal of Pharmacology.

In The Last Decade

Arjun Muralidharan

18 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arjun Muralidharan Australia 13 192 142 110 71 43 19 423
Alfhild Grönbladh Sweden 15 119 0.6× 127 0.9× 169 1.5× 35 0.5× 47 1.1× 43 598
Lanxiang Wu China 10 222 1.2× 86 0.6× 93 0.8× 44 0.6× 15 0.3× 26 484
Niloofar Rezvani United States 6 328 1.7× 300 2.1× 149 1.4× 51 0.7× 62 1.4× 10 660
Xiao‐Hui Xiang China 15 96 0.5× 109 0.8× 139 1.3× 47 0.7× 8 0.2× 27 499
Marc J. Barjavel France 10 191 1.0× 159 1.1× 84 0.8× 27 0.4× 23 0.5× 11 425
Chihiro Kaneko Japan 11 357 1.9× 299 2.1× 164 1.5× 70 1.0× 17 0.4× 15 678
Kristof Deseure Belgium 14 330 1.7× 221 1.6× 126 1.1× 53 0.7× 26 0.6× 22 472
Ajay Yekkirala United States 12 290 1.5× 339 2.4× 376 3.4× 84 1.2× 44 1.0× 17 664
I. Angel France 16 171 0.9× 232 1.6× 267 2.4× 80 1.1× 26 0.6× 35 670
Aaron C. Overland United States 9 235 1.2× 252 1.8× 219 2.0× 47 0.7× 27 0.6× 11 498

Countries citing papers authored by Arjun Muralidharan

Since Specialization
Citations

This map shows the geographic impact of Arjun Muralidharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjun Muralidharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjun Muralidharan more than expected).

Fields of papers citing papers by Arjun Muralidharan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjun Muralidharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjun Muralidharan. The network helps show where Arjun Muralidharan may publish in the future.

Co-authorship network of co-authors of Arjun Muralidharan

This figure shows the co-authorship network connecting the top 25 collaborators of Arjun Muralidharan. A scholar is included among the top collaborators of Arjun Muralidharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjun Muralidharan. Arjun Muralidharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
3.
Muralidharan, Arjun, et al.. (2022). Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials. Discover Oncology. 13(1). 108–108. 3 indexed citations
4.
Muralidharan, Arjun, Alexander Samoshkin, Marino Convertino, et al.. (2021). Identification and characterization of novel candidate compounds targeting 6‐ and 7‐transmembrane μ‐opioid receptor isoforms. British Journal of Pharmacology. 178(13). 2709–2726. 3 indexed citations
5.
Muralidharan, Arjun, Susana G. Sotocinal, Jean‐Sebastien Austin, & Jeffrey S. Mogil. (2020). The influence of aging and duration of nerve injury on the antiallodynic efficacy of analgesics in laboratory mice. PAIN Reports. 5(3). e824–e824. 13 indexed citations
6.
Khuong, Thang M., et al.. (2019). Peripheralstraightjacket(α2δ Ca2+channel subunit) expression is required for neuropathic sensitization inDrosophila. Philosophical Transactions of the Royal Society B Biological Sciences. 374(1785). 20190287–20190287. 11 indexed citations
7.
Muralidharan, Arjun. (2017). Establishment and Characterization of a Novel Rat Model of Mechanical Low Back Pain Using Behavioral, Pharmacologic and Histologic Methods. Frontiers in Pharmacology. 8. 493–493. 19 indexed citations
9.
Muralidharan, Arjun, et al.. (2016). Comparison of Burrowing and Stimuli-Evoked Pain Behaviors as End-Points in Rat Models of Inflammatory Pain and Peripheral Neuropathic Pain. Frontiers in Behavioral Neuroscience. 10. 88–88. 28 indexed citations
10.
Smith, Maree T. & Arjun Muralidharan. (2014). Pain pharmacology and the pharmacological management of pain. Memory & Cognition. 35(6). 159–180. 2 indexed citations
11.
Smith, Maree T. & Arjun Muralidharan. (2014). Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain. Expert Opinion on Therapeutic Targets. 19(1). 25–35. 31 indexed citations
12.
Muralidharan, Arjun, Bruce Wyse, & Maree T. Smith. (2013). Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer-Induced Bone Pain. Pain Medicine. 15(1). 93–110. 42 indexed citations
13.
Muralidharan, Arjun, Bruce Wyse, & Maree T. Smith. (2013). Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods. Pharmacology Biochemistry and Behavior. 106. 33–46. 25 indexed citations
14.
Muralidharan, Arjun & Maree T. Smith. (2013). Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. Inflammopharmacology. 21(5). 339–363. 32 indexed citations
15.
16.
Smith, Maree T. & Arjun Muralidharan. (2012). Pharmacogenetics of pain and analgesia. Clinical Genetics. 82(4). 321–330. 23 indexed citations
17.
Muralidharan, Arjun & Maree T. Smith. (2011). Pain, analgesia and genetics. Journal of Pharmacy and Pharmacology. 63(11). 1387–1400. 39 indexed citations
18.
Yogeeswari, Perumal, et al.. (2011). Discovery of molecules for the treatment of neuropathic pain: Synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl)furoic-2-acid hydrazones. European Journal of Medicinal Chemistry. 46(7). 2964–2970. 22 indexed citations
19.
Pandey, Dilip K., et al.. (2009). A novel 5-HT2A receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: Approaching early-onset antidepressants. Pharmacology Biochemistry and Behavior. 94(3). 363–373. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026